Sonia Jaramillo
5PUBLICATIONS
22CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Apr 14, 2026
Inhibition of high CXCR4 with motixafortide and absence of single-cell MRD predict outcome after AML consolidation.Enise Ceran, Sonia Jaramillo, Anne Kathrin Merbach
|Sep 15, 2023
Q-HAM: a multicenter upfront randomized phase II trial of quizartinib and high-dose Ara-C plus mitoxantrone in relapsed/refractory AML with FLT3-ITD.Sonia Jaramillo, Lucian Le Cornet, Markus Kratzmann
|Jul 18, 2022
Ruxolitinib is effective in the treatment of a patient with refractory T-ALL.Sonia Jaramillo, Hannah Hennemann, Peter Horak
|Nov 04, 2021
Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML.Sonia Jaramillo, Johannes Krisam, Lucian Le Cornet
|Jul 17, 2021
Post-Induction Treatment for Acute Myeloid Leukemia: Something Change?Sonia Jaramillo, Richard F Schlenk
Pageof 1
Frequent Collaborators
1 joint publications
Richard F Schlenk
1 joint publications
Anne Kathrin Merbach
1 joint publications
Christian Rohde
1 joint publications
Judith Schaffrath
1 joint publications
Adam Sciambi
1 joint publications
Kathrin Rieger
1 joint publications
Friedrich Stölzel
1 joint publications
Christoph Röllig
1 joint publications
Michelle Lotze
1 joint publications
Christian H Brandts
